Vertex Pharma names new CMO

Vertex Pharmaceuticals (VRTX) says Chief Medical Officer Robert Kauffman is retiring in H2.

He will be replaced by Merck (MRK) veteran Jeffrey Chodakewitz. (PR)

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs